Wednesday, January 19, 2022
News for Retirees


Hashish and diabetic ketoacidosis, Medicare protection of CGMs

Share this…FacebookPinterestTwitterLinkedin December 28, 2021 1 min learn ADD TOPIC TO EMAIL ALERTS Obtain an…

By Staff , in Medicare , at December 28, 2021



December 28, 2021

1 min learn


We have been unable to course of your request. Please attempt once more later. If you happen to proceed to have this subject please contact [email protected]

A current research means that hashish use could trigger signs much like diabetic ketoacidosis in sufferers with sort 1 diabetes. A evaluation of the info was the highest story in endocrinology final week.

The second prime story was a couple of ultimate CMS rule that can increase Medicare protection of steady glucose displays.



Supply: Adobe Inventory

Learn these and extra in endocrinology beneath:

Hashish use could trigger DKA-like signs in sort 1 diabetes

Sufferers with sort 1 diabetes presenting with signs of diabetic ketoacidosis could as an alternative have ketosis because of hashish hyperemesis syndrome, and several other standards may also help keep away from a misdiagnosis, in accordance with knowledge printed in Diabetes Care. Learn extra.

CMS expands Medicare protection for all CGMs

CMS will increase Medicare protection for every type of steady glucose displays, together with adjunctive and non-adjunctive CGMs. The ultimate rule, issued Dec. 21, classifies adjunctive CGMs underneath the Medicare Half B profit for sturdy medical tools (DME) and finalizes sure DME fee provisions that have been included in two interim ultimate guidelines. Learn extra.

New medication convey twin advantages for ‘intertwined’ diabetic kidney illness, CVD

Diabetic kidney illness is the main reason for end-stage renal illness within the U.S., and 50% of adults initiating renal alternative remedy have diabetes, in accordance with the CDC. Learn extra.

FDA approves second insulin glargine biosimilar

The FDA accredited insulin glargine-aglr, a second biosimilar to Sanofi’s insulin glargine, to enhance glycemic response in youngsters and adults with sort 1 diabetes and adults with sort 2 diabetes. Learn extra.

Practically one-third of adults prescribed hybrid closed-loop system don’t provoke auto mode

About 31% of a bunch of adults with sort 1 diabetes prescribed a hybrid closed-loop insulin supply system by no means initiated auto mode, and half of the by no means initiated group consisted of Black and Hispanic sufferers, in accordance with research knowledge. Learn extra.



Source link

Skip to content